Publications

Filter by Category

All Blog Presentations Press Releases Publications Videos

Filter by Program

Filter by Publish Date

January 10, 2015

A Collaborative Approach for “ReSeq-Ing” Mycobacterium Tuberculosis Drug Resistance: Convergence for Drug and Diagnostic Developers

January 10, 2015

Global Collaboration to Develop New and Existing Drugs for Neonates

Davis JM, Turner MA. Global Collaboration to Develop New and Existing Drugs for Neonates. JAMA pediatrics. 2015 Oct;169(10):887–

The Power is in Your Hands: Duchenne Regulatory Science Consortium

Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease

Stephenson D, Hu MT, Romero K, Breen K, Burn D, Ben-Shlomo Y, Bhattaram A, Isaac M, Venuto C, Kubota K, Little MA, Friend S, Loves

Global Efforts to Accelerate the Development of Safe and Efficacious Therapies for Newborns

Evidentiary Considerations

An Evidence-Based Drug Development Tool for Tuberculosis Regimens: The Hollow Fiber System Model

Strategic Regulatory Evaluation and Endorsement of the Hollow Fiber Tuberculosis System as a Novel Drug Development Tool

Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments

Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments

Previous2223 24...32 Next